Amarin reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acceleron Pharma XLRN:US $ 0M 0M
Aerie Pharmaceuticals AERI:US $ 222.02M 5.94M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Amarin AMRN:US $ 0M 0M
Arena Pharmaceuticals ARNA:US $ 38.78M 1.25M
AstraZeneca AZN:LN 24601M 6727M
Biocryst Pharmaceuticals BCRX:US $ 263.66M 9.32M
Epizyme EPZM:US $ 231.2M 691K
Esperion Therapeutics ESPR:US $ 272.1M 404K
GlaxoSmithKline GSK:LN 20442M 2605M
Halozyme Therapeutics HALO:US $ 785.57M 0.84M
Heron Therapeutics HRTX:US $ 148.98M 148.98M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
IONIS PHARMACEUT IONS:US $ 1240.7M 369.78M
JAZZ PHA JAZZ:US $ 6495.33M 4642.3M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Novartis NOVN:VX SF 26491M 908M
Teva Pharmaceutical Industries TEVA:US $ 21602M 686M